0001894562-24-000018.txt : 20240304 0001894562-24-000018.hdr.sgml : 20240304 20240304212021 ACCESSION NUMBER: 0001894562-24-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marrazzo Jeffrey D CENTRAL INDEX KEY: 0001631262 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41536 FILM NUMBER: 24717989 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prime Medicine, Inc. CENTRAL INDEX KEY: 0001894562 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-465-0013 MAIL ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wk-form4_1709605211.xml FORM 4 X0508 4 2024-02-29 0 0001894562 Prime Medicine, Inc. PRME 0001631262 Marrazzo Jeffrey D C/O PRIME MEDICINE, INC. 21 ERIE STREET CAMBRIDGE MA 02139 1 0 0 0 0 Stock Option (right to buy) 8.63 2024-02-29 4 A 0 250000 0 A 2034-02-28 Common Stock 250000 250000 D The shares underlying this option shall vest in full on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service through such vesting date. /s/ Karen Brown, attorney-in-fact 2024-03-04